MedTrace Logo

Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone

NCT00519584 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 218

Last updated 2017-07-21

Study results available
· View outcomes & findings →

Summary

This study will test the hypothesis that ropivacaine in combination with either systemic or local steroid provides comparably longer-lasting analgesia tha ropivacaine alone.

Conditions

Interventions

DRUG

Ropivacaine

30 ml 0.5%

DRUG

dex

8 mg (2 ml)

DRUG

Bupivacaine

30 ml 0.5%

DRUG

Saline

0.9% saline; systemic and local

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Kenneth Cummings III, M.D. · Cleveland Clinic/Hillcrest

  • Daniel I Sessler, MD · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00519584 on ClinicalTrials.gov